Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Anti-Obesity Prescription Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Anti-Obesity Prescription Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Anti-Obesity Prescription Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Orexigen Therapeutics
F Hoffmann La Roche
Novo Nordisk
VIVUS
Arena Pharmaceuticals
By Type:
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
By End-User:
Hospitals Pharmacies
Retail Pharmacies
E-commerce
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-Obesity Prescription Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Bupropion and Naltrexone from 2016 to 2027
-
1.3.2 USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Orlistat from 2016 to 2027
-
1.3.3 USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Lorcaserin from 2016 to 2027
-
1.3.4 USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Phentermine and Topiramate from 2016 to 2027
-
1.3.5 USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Liraglutide from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Hospitals Pharmacies from 2016 to 2027
-
1.4.2 USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.3 USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of E-commerce from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Anti-Obesity Prescription Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anti-Obesity Prescription Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Bupropion and Naltrexone
-
3.4.2 Market Size and Growth Rate of Orlistat
-
3.4.3 Market Size and Growth Rate of Lorcaserin
-
3.4.4 Market Size and Growth Rate of Phentermine and Topiramate
-
3.4.5 Market Size and Growth Rate of Liraglutide
4 Segmentation of Anti-Obesity Prescription Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anti-Obesity Prescription Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Anti-Obesity Prescription Drugs in Hospitals Pharmacies
-
4.4.2 Market Size and Growth Rate of Anti-Obesity Prescription Drugs in Retail Pharmacies
-
4.4.3 Market Size and Growth Rate of Anti-Obesity Prescription Drugs in E-commerce
5 Market Analysis by Regions
-
5.1 USA Anti-Obesity Prescription Drugs Production Analysis by Regions
-
5.2 USA Anti-Obesity Prescription Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Anti-Obesity Prescription Drugs Landscape Analysis
-
6.1 West USA Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
6.2 West USA Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
7 South USA Anti-Obesity Prescription Drugs Landscape Analysis
-
7.1 South USA Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
7.2 South USA Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
8 Middle West USA Anti-Obesity Prescription Drugs Landscape Analysis
-
8.1 Middle West USA Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
9 Northeast USA Anti-Obesity Prescription Drugs Landscape Analysis
-
9.1 Northeast USA Anti-Obesity Prescription Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Anti-Obesity Prescription Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Orexigen Therapeutics
-
10.1.1 Orexigen Therapeutics Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 F Hoffmann La Roche
-
10.2.1 F Hoffmann La Roche Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Novo Nordisk
-
10.3.1 Novo Nordisk Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 VIVUS
-
10.4.1 VIVUS Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Arena Pharmaceuticals
-
10.5.1 Arena Pharmaceuticals Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Bupropion and Naltrexone from 2016 to 2027
-
Figure USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Orlistat from 2016 to 2027
-
Figure USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Lorcaserin from 2016 to 2027
-
Figure USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Phentermine and Topiramate from 2016 to 2027
-
Figure USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Liraglutide from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Hospitals Pharmacies from 2016 to 2027
-
Figure USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure USA Anti-Obesity Prescription Drugs Market Size and Growth Rate of E-commerce from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Anti-Obesity Prescription Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Anti-Obesity Prescription Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Anti-Obesity Prescription Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anti-Obesity Prescription Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Anti-Obesity Prescription Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Bupropion and Naltrexone
-
Figure Market Size and Growth Rate of Orlistat
-
Figure Market Size and Growth Rate of Lorcaserin
-
Figure Market Size and Growth Rate of Phentermine and Topiramate
-
Figure Market Size and Growth Rate of Liraglutide
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Anti-Obesity Prescription Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Anti-Obesity Prescription Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of E-commerce
-
Table USA Anti-Obesity Prescription Drugs Production by Regions
-
Table USA Anti-Obesity Prescription Drugs Production Share by Regions
-
Figure USA Anti-Obesity Prescription Drugs Production Share by Regions in 2016
-
Figure USA Anti-Obesity Prescription Drugs Production Share by Regions in 2021
-
Figure USA Anti-Obesity Prescription Drugs Production Share by Regions in 2027
-
Table USA Anti-Obesity Prescription Drugs Consumption by Regions
-
Table USA Anti-Obesity Prescription Drugs Consumption Share by Regions
-
Figure USA Anti-Obesity Prescription Drugs Consumption Share by Regions in 2016
-
Figure USA Anti-Obesity Prescription Drugs Consumption Share by Regions in 2021
-
Figure USA Anti-Obesity Prescription Drugs Consumption Share by Regions in 2027
-
Table West USA Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table West USA Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure West USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure West USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table West USA Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure West USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure West USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table South USA Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table South USA Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure South USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure South USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table South USA Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure South USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure South USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table Middle West USA Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Anti-Obesity Prescription Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Anti-Obesity Prescription Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Anti-Obesity Prescription Drugs Consumption Share by Types in 2027
-
Table Northeast USA Anti-Obesity Prescription Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Anti-Obesity Prescription Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Anti-Obesity Prescription Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Orexigen Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orexigen Therapeutics
-
Figure Sales and Growth Rate Analysis of Orexigen Therapeutics
-
Figure Revenue and Market Share Analysis of Orexigen Therapeutics
-
Table Product and Service Introduction of Orexigen Therapeutics
-
Table Company Profile and Development Status of F Hoffmann La Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann La Roche
-
Figure Sales and Growth Rate Analysis of F Hoffmann La Roche
-
Figure Revenue and Market Share Analysis of F Hoffmann La Roche
-
Table Product and Service Introduction of F Hoffmann La Roche
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of VIVUS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of VIVUS
-
Figure Sales and Growth Rate Analysis of VIVUS
-
Figure Revenue and Market Share Analysis of VIVUS
-
Table Product and Service Introduction of VIVUS
-
Table Company Profile and Development Status of Arena Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arena Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Arena Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Arena Pharmaceuticals
-
Table Product and Service Introduction of Arena Pharmaceuticals
-
